The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS)

European Journal of Preventive Cardiology

Volumn 23, Issue 18, 2016, Pages 1914-1939

  Rauch, Bernhard ^a   Davos, Constantinos H ^b   Doherty, Patrick ^c   Saure, Daniel ^d   Metzendorf, Maria Inti ^e   Salzwedel, Annett ^f   Völler, Heinz ^f   Jensen, Katrin ^d   Schmid, Jean Paul ^g  

^a IHF Institut für Herzinfarktforschung   (Germany)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF POTSDAM   (Germany)

^g Spital Bern Tiefenau   (Switzerland)

Author keywords

acute coronary syndrome; coronary artery disease; coronary bypass grafting; hospital readmission; mortality; Rehabilitation

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; GENETIC HETEROGENEITY; HEART MUSCLE REVASCULARIZATION; HEART REHABILITATION; HUMAN; META ANALYSIS; MORTALITY RATE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROPENSITY SCORE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; HEART MUSCLE ISCHEMIA; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME;

CARDIAC REHABILITATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; TREATMENT OUTCOME;

EID: 84994482319     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487316671181     Document Type: Review

References (54)

1. Anderson L, Oldridge N, Thompson DR, et al. Exercise-based cardiac rehabilitation for coronary heart disease. J Am Coll Cardiol 2016; 67 (1): 1-12.
2. Goel K, Lennon RJ, Tilbury RT, et al. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 2011; 123 (21): 2344-2352.
3. Goel K, Pack QR, Lahr B, et al. Cardiac rehabilitation is associated with reduced long-term mortality in patients undergoing combined heart valve and CABG surgery. Eur J Prev Cardiol 2015; 22 (2): 159-168.
4. Suaya JA, Stason WB, Ades PA, et al. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol 2009; 54 (1): 25-33.
5. Norris CM, Jensen LA, Galbraith PD, et al. Referral rate and outcomes of cardiac rehabilitation after cardiac catheterization in a large Canadian city. J Cardiopulm Rehabil 2004; 24: 392-400.
6. Alter DA, Oh PI, Chong A,. Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system. Eur J Cardiovasc Prev Rehabil 2009; 16 (1): 102-113.
7. Martin BJ, Hauer T, Arena R, et al. Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation 2012; 126 (6): 677-687.
8. Rauch B, Riemer T, Schwaab B, et al. Short-term comprehensive cardiac rehabilitation after AMI is associated with reduced 1-year mortality: results from the OMEGA study. Eur J Prev Cardiol 2014; 21: 1060-1069.
9. Giannuzzi P, Temporelli PL, Marchioli R, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008; 168 (20): 2194-2204.
10. Lawler PR, Filion KB, Eisenberg MJ,. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2011; 162 (4): 571-584.
11. Janssen V, De Gucht V, Dusseldorp E, et al. Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol 2013; 20 (4): 620-640.
12. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124: 2458-2473.
13. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2016; 37 (29): 2315-2381.
14. Bjarnason-Wehrens B, McGee H, Zwisler AD, et al. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey. Eur J Cardiovasc Prev Rehabil 2010; 17: 410-418.
15. Zwisler AD, Bjarnason-Wehrens B, McGee H, et al. Can level of education, accreditation and use of databases in cardiac rehabilitation be improved? Results from the European Cardiac Rehabilitation Inventory Survey. Eur J Cardiovasc Prev Rehabil 2012; 19: 143-150.
16. Johannesson M, Jonsson B, Kjekshus J, et al. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med 1997; 336 (5): 332-336.
17. Montalescot G, Andersen HR, Antoniucci D, et al. Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart 2004; 90 (6): e37-e37.
18. Karoff M, Held K, Bjarnason-Wehrens B,. Cardiac rehabilitation in Germany. Eur J Cardiovasc Prev Rehabil 2007; 14 (1): 18-27.
19. Zwisler AD, Soja AM, Rasmussen S, et al. Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial. Am Heart J 2008; 155 (6): 1106-1113.
20. West RR, Jones DA, Henderson AH,. Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction. Heart 2012; 98 (8): 637-644.
21. Pack QR, Goel K, Lahr BD, et al. Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: a community-based study. Circulation 2013; 128 (6): 590-597.
22. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1-1.
23. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology-a proposal of reporting. JAMA 2000; 283 (15): 2008-2012.
24. Cole JA, Smith SM, Hart N, et al. Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease. Cardiol Res Pract 2011; 2011: 232-351.
25. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011; 7: CD001800-CD001800.
26. Wells GA, Shea B, Higgins JP, et al. Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews. Res Synth Methods 2013; 4 (1): 63-77.
27. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp (2008).
28. Symons MJ, Moore DT,. Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 2002; 55 (9): 893-899.
29. Higgins JPT, Green SE,. Cochrane Handbook for Systematic Reviews of Interventions, Chichester, UK: John Wiley & Sons, Ltd, 2011.
30. De Vries H, Kemps HMC, Van Engen Verheul MM, et al. Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients. Eur Heart J 2015; 36 (24): 1519-1528.
31. Kim C, Kim DY, Moon CJ,. Prognostic influences of cardiac rehabilitation in Korean acute myocardial infarction patients. Ann Rehabil Med 2011; 35 (3): 375-380.
32. Schwaab B, Waldmann A, Katalinic A, et al. In-patient cardiac rehabilitation versus medical care-a prospective multicentre controlled 12 months follow-up in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 2011; 18 (4): 581-586.
33. Milani RV, Lavie CJ,. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med 2007; 120 (9): 799-806.
34. Hansen D, Dendale P, Leenders M, et al. Reduction of cardiovascular event rate: different effects of cardiac rehabilitation in CABG and PCI patients. Acta Cardiol 2009; 64 (5): 639-644.
35. Higgins JP, Ramsay C, Reeves BC, et al. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods 2013; 4 (1): 12-25.
36. Boulay P, Prud'homme D,. Health-care consumption and recurrent myocardial infarction after 1 year of conventional treatment versus short- and long-term cardiac rehabilitation. Prev Med 2004; 38 (5): 586-593.
37. Kutner NG, Zhang R, Huang Y, et al. Cardiac rehabilitation and survival of dialysis patients after coronary bypass. J Am Soc Nephrol 2006; 17 (4): 1175-1180.
38. Nielsen KM, Faergeman O, Foldspang A, et al. Cardiac rehabilitation: health characteristics and socio-economic status among those who do not attend. Eur J Public Health 2008; 18 (5): 479-483.
39. Junger C, Rauch B, Schneider S, et al. Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality. Curr Med Res Opin 2010; 26 (4): 803-811.
40. Waldmann A, Katalinic A, Schwaab B, et al. The TeleGuard trial of additional telemedicine care in CAD patients. Morbidity and mortality after 12 months. J Telemed Telecare 2008; 14: 22-26.
41. Beauchamp A, Worcester M, Ng A, et al. Attendance at cardiac rehabilitation is associated with lower all-cause mortality after 14 years of follow-up. Heart 2013; 99 (9): 620-625.
42. Worcester MU, Murphy BM, Mee VK, et al. Cardiac rehabilitation programmes: predictors of non-attendance and drop-out. Eur J Cardiovasc Prev Rehabil 2004; 11: 328-335.
43. Lee HY, Kim JH, Kim BO, et al. Regular exercise training reduces coronary restenosis after percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol 2013; 167 (6): 2617-2622.
44. Marzolini S, Leung YW, Alter DA, et al. Outcomes associated with cardiac rehabilitation participation in patients with musculoskeletal comorbidities. Eur J Phys Rehabil Med 2013; 49: 775-783.
45. Grace SL, Russell KL, Reid RD, et al. Effect of cardiac rehabilitation referral strategies on utilization rates: a prospective, controlled study. Arch Intern Med 2011; 171 (3): 235-241.
46. Coll-Fernandez R, Coll R, Pascual T, et al. Cardiac rehabilitation and outcome in stable outpatients with recent myocardial infarction. Arch Phys Med Rehabil 2014; 95: 322-329.
47. Barba R, Bisbe J, Pedrajas JN, et al. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil 2009; 16: 457-463.
48. Prince DZ, Sobolev M, Gao J, et al. Racial disparities in cardiac rehabilitation initiation and the effect on survival. PM R 2014; 6 (6): 486-492.
49. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010; 122: 2152-2129.
50. Meurs M, Burger H, van Riezen J, et al. The association between cardiac rehabilitation and mortality risk for myocardial infarction patients with and without depressive symptoms. J Affect Disord 2015; 188: 278-283.
51. Spijkerman TA, van den Brink RHS, May JF, et al. Decreased impact of post-myocardial infarction depression on cardiac prognosis? J Psychosom Res 2006; 61: 493-499.
52. van den Brink RHS, Van Melle JP, Honig A, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002; 144: 219-225.
53. Schlitt A, Wischmann P, Wienke A, et al. Rehabilitation in patients with coronary heart disease. Dtsch Arztebl Int 2015; 112: 527-534.
54. Schulz S, Schlitt A, Lutze A, et al. The importance of genetic variants in TNF alpha for periodontal disease in a cohort of coronary patients. J Clin Periodontol 2012; 39: 699-706.